Cargando…
The Value of Early Tumor Size Response to Chemotherapy in Pediatric Rhabdomyosarcoma
SIMPLE SUMMARY: Rhabdomyosarcoma is the most common soft tissue sarcoma in childhood. At diagnosis, tumor and patient characteristics determine the prognosis and subsequent treatment stratification. There are currently no early biomarkers that identify good or poor responders to chemotherapy regimen...
Autores principales: | van Ewijk, Roelof, Vaarwerk, Bas, Breunis, Willemijn B., Schoot, Reineke A., ter Horst, Simone A. J., van Rijn, Rick R., van der Lee, Johanna H., Merks, Johannes H. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866196/ https://www.ncbi.nlm.nih.gov/pubmed/33561094 http://dx.doi.org/10.3390/cancers13030510 |
Ejemplares similares
-
Methodological considerations on segmenting rhabdomyosarcoma with diffusion-weighted imaging—What can we do better?
por: Chatziantoniou, Cyrano, et al.
Publicado: (2023) -
Imaging in rhabdomyosarcoma: a patient journey
por: de Vries, Isabelle S. A., et al.
Publicado: (2023) -
Correction to: Imaging in rhabdomyosarcoma: a patient journey
por: de Vries, Isabelle S. A., et al.
Publicado: (2023) -
European guideline for imaging in paediatric and adolescent rhabdomyosarcoma — joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology
por: van Ewijk, Roelof, et al.
Publicado: (2021) -
Imaging findings in noncraniofacial childhood rhabdomyosarcoma
por: Van Rijn, Rick R., et al.
Publicado: (2008)